Octant Bio

Octant Bio is a biotechnology company that leverages cutting-edge single-cell and CRISPR genomic technologies to accelerate drug discovery. The company's mission is to transform drug discovery by building a platform that enables the identification of new therapeutic targets and the development of precision medicines. Octant Bio's proprietary platform combines high-throughput single-cell transcriptomics, machine learning, and CRISPR genome engineering to generate data-driven insights that inform the development of new drugs. The company's technology has applications in multiple therapeutic areas, including oncology, neuroscience, and immunology.

Octant Bio's Investors